Le Lézard
Classified in: Health, Science and technology
Subject: WOM

Volpara Health Technologies Attains ISO27001 Information Security Certification


WELLINGTON, New Zealand, Sept. 18, 2018 /PRNewswire/ -- Volpara Health Technologies (VHT), the industry leader in breast imaging analytics, announced today that the company has achieved ISO/IEC 27001:2013 Information Security Management System (ISMS) certification, confirming that VHT and all its subsidiaries and related products comply with the highest data security standards. Validated by an independent auditor, the British Standards Institution (BSI), the certification covers the design, development, delivery, and support of its breast imaging analytics software.

Established by the International Organization for Standardization (ISO), the ISO/IEC 27001 standard requires the certification of an organization's information security management controls for areas such as data security and business continuity. The certification extends to every level of an organization's IT infrastructure, including asset management, access control, human resource security, and application security.

Gareth Beaumont, Volpara's Chief Architect and Information Security Officer, said: "As a global company, Volpara works with patient data and confidential information from large and small healthcare enterprises in over 36 countries. Compliance with the ISO 27001:2013 standard demonstrates Volpara's strong and continuing commitment to data security and PHI privacy through policies, procedures, practices, and employee training. We view ISO certification as the baseline for data privacy and security. For instance, our VolparaEnterprise® platform also leverages industry best practices to secure patient data and ensure confidentiality."

VHT's flagship VolparaEnterprise software delivers key performance indicators for over 100 performance and quality metrics, including patient positioning and compression, which are widely viewed as the causes of most clinical image deficiencies associated with delayed breast cancer detection. VolparaEnterprise software enables facilities to perform rapid quality control checks that help optimize the productivity and efficiency of imaging resources. This in turn helps decrease costs through the reduction of retakes, increase employee effectiveness, and enhance the patient experience.

About Volpara Solutions
Founded with the goal of helping radiologists give women the most accurate information possible regarding their breast health, Volpara Solutions is the wholly owned sales and marketing arm of Volpara Health Technologies Limited of New Zealand. Available in most markets where breast cancer screening is commonplace, Volpara®Densitytm software provides an objective volumetric measure of breast density from both digital mammography and tomosynthesis data. VolparaEnterprise software is a suite of quantitative breast imaging tools for personalized measurements of density, patient-specific x-ray dose, breast compression, breast positioning, and other factors designed to provide critical insight for breast imaging workflow. For more information, visit www.volparasolutions.com.

SOURCE Volpara Solutions


These press releases may also interest you

at 03:26
Allied Market Research published a report, titled, "E-waste Disposal Market by Material (Metal, Plastic, Glass,...

at 03:25
UnionPay International (UPI) has teamed up with JD PAY, JD.com's digital payment service to elevate the cross-border shopping experience, enabling customers around the world to use their local UnionPay cards on JD.com. This partnership is a major...

at 03:25
A news report from China Daily: Greater efforts are needed to strengthen international cooperation in science and technology, explore...

at 03:05
Global logistics service provider J&T Express (HKEX: 1519) today announced its inaugural Environmental, Social and Governance Report, showcasing efforts and key achievements in 2023 in the areas of corporate governance, environmental protection,...

at 02:48
Today, RaySearch Laboratories AB (publ)  publishes its Annual Report for the financial year 2023. The report is held available on RaySearch's website, under the section Investors.  This information is information that RaySearch Larboratiories AB...

at 02:41
Implantica AG (publ), a med-tech company at the forefront of bringing advanced technology into the body, is publishing its annual report for the fiscal year 2023. The annual report is now available on the company's website. "Implantica had a very...



News published on and distributed by: